Form D · Biotechnology
ALRGN Bio, Inc.
Greensboro, NC · CIK 0001677272
Offering snapshot reported Dec 20, 2016 · SEC filing
- Reported sold
- $946K Offering amount: $946K
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2016 | Initial | $946,188 | No comparison | 21 | SEC filing |
| Jun 23, 2016 | Initial | $99,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276658
Source: Form D, filed Dec 20, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Drozd | Director |
| Kit Mc Quiston | Director, Executive, Promoter |
| Ann Russell | Executive |
| Nicholas Walsh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2901 East Gate City Blvd Suite 2400
Greensboro, NC, 27401
Greensboro, NC, 27401